|
CHEMBL1795139
|
Q8IU80
|
Transmembrane protease serine 6 |
99.50%
|
98.33%
|
|
CHEMBL2581
|
P07339
|
Cathepsin D |
99.31%
|
98.95%
|
|
CHEMBL4588
|
P22894
|
Matrix metalloproteinase 8 |
98.54%
|
94.66%
|
|
CHEMBL230
|
P35354
|
Cyclooxygenase-2 |
98.48%
|
89.63%
|
|
CHEMBL4018
|
P49146
|
Neuropeptide Y receptor type 2 |
98.43%
|
98.94%
|
|
CHEMBL2514
|
O95665
|
Neurotensin receptor 2 |
98.39%
|
100.00%
|
|
CHEMBL3251
|
P19838
|
Nuclear factor NF-kappa-B p105 subunit |
97.97%
|
96.09%
|
|
CHEMBL4026
|
P40763
|
Signal transducer and activator of transcription 3 |
97.28%
|
82.69%
|
|
CHEMBL4657
|
Q6V1X1
|
Dipeptidyl peptidase VIII |
97.27%
|
97.21%
|
|
CHEMBL253
|
P34972
|
Cannabinoid CB2 receptor |
96.82%
|
97.25%
|
|
CHEMBL2730
|
P21980
|
Protein-glutamine gamma-glutamyltransferase |
96.66%
|
92.38%
|
|
CHEMBL3137262
|
O60341
|
LSD1/CoREST complex |
96.31%
|
97.09%
|
|
CHEMBL4979
|
P13866
|
Sodium/glucose cotransporter 1 |
96.11%
|
98.24%
|
|
CHEMBL335
|
P18031
|
Protein-tyrosine phosphatase 1B |
95.96%
|
95.17%
|
|
CHEMBL4801
|
P29466
|
Caspase-1 |
95.83%
|
96.85%
|
|
CHEMBL237
|
P41145
|
Kappa opioid receptor |
95.72%
|
98.10%
|
|
CHEMBL4123
|
P30989
|
Neurotensin receptor 1 |
95.41%
|
96.67%
|
|
CHEMBL3130
|
O00329
|
PI3-kinase p110-delta subunit |
94.98%
|
96.47%
|
|
CHEMBL2492
|
P36544
|
Neuronal acetylcholine receptor protein alpha-7 subunit |
94.63%
|
88.42%
|
|
CHEMBL1907591
|
P30926
|
Neuronal acetylcholine receptor; alpha4/beta4 |
94.26%
|
100.00%
|
|
CHEMBL3359
|
P21462
|
Formyl peptide receptor 1 |
94.17%
|
93.56%
|
|
CHEMBL4777
|
P25929
|
Neuropeptide Y receptor type 1 |
94.12%
|
96.67%
|
|
CHEMBL3837
|
P07711
|
Cathepsin L |
93.76%
|
96.61%
|
|
CHEMBL283
|
P08254
|
Matrix metalloproteinase 3 |
93.41%
|
97.29%
|
|
CHEMBL5845
|
P23415
|
Glycine receptor subunit alpha-1 |
93.36%
|
90.71%
|
|
CHEMBL3060
|
Q9Y345
|
Glycine transporter 2 |
93.29%
|
99.17%
|
|
CHEMBL3176
|
O43603
|
Galanin receptor 2 |
93.10%
|
98.89%
|
|
CHEMBL4361
|
Q07820
|
Induced myeloid leukemia cell differentiation protein Mcl-1 |
92.98%
|
95.52%
|
|
CHEMBL4793
|
Q86TI2
|
Dipeptidyl peptidase IX |
92.61%
|
96.95%
|
|
CHEMBL1944495
|
P28065
|
Proteasome subunit beta type-9 |
92.47%
|
97.50%
|
|
CHEMBL3807
|
P17706
|
T-cell protein-tyrosine phosphatase |
92.42%
|
93.00%
|
|
CHEMBL3437
|
Q16853
|
Amine oxidase, copper containing |
92.19%
|
94.00%
|
|
CHEMBL340
|
P08684
|
Cytochrome P450 3A4 |
92.03%
|
91.19%
|
|
CHEMBL1907594
|
P30926
|
Neuronal acetylcholine receptor; alpha3/beta4 |
91.79%
|
97.23%
|
|
CHEMBL4203
|
Q9HAZ1
|
Dual specificity protein kinase CLK4 |
91.56%
|
94.45%
|
|
CHEMBL3468
|
P55210
|
Caspase-7 |
91.46%
|
95.68%
|
|
CHEMBL2107
|
P61073
|
C-X-C chemokine receptor type 4 |
91.07%
|
93.10%
|
|
CHEMBL4581
|
P52732
|
Kinesin-like protein 1 |
90.97%
|
93.18%
|
|
CHEMBL4227
|
P25090
|
Lipoxin A4 receptor |
90.82%
|
100.00%
|
|
CHEMBL2069156
|
Q14145
|
Kelch-like ECH-associated protein 1 |
90.69%
|
82.38%
|
|
CHEMBL4625
|
Q07817
|
Apoptosis regulator Bcl-X |
90.67%
|
99.77%
|
|
CHEMBL5043
|
Q6P179
|
Endoplasmic reticulum aminopeptidase 2 |
90.60%
|
91.81%
|
|
CHEMBL1075094
|
Q16236
|
Nuclear factor erythroid 2-related factor 2 |
89.84%
|
96.00%
|
|
CHEMBL5203
|
P33316
|
dUTP pyrophosphatase |
89.71%
|
99.18%
|
|
CHEMBL236
|
P41143
|
Delta opioid receptor |
89.66%
|
99.35%
|
|
CHEMBL2693
|
Q9UIQ6
|
Cystinyl aminopeptidase |
89.39%
|
97.64%
|
|
CHEMBL2001
|
Q9H244
|
Purinergic receptor P2Y12 |
89.22%
|
96.00%
|
|
CHEMBL5619
|
P27695
|
DNA-(apurinic or apyrimidinic site) lyase |
88.99%
|
91.11%
|
|
CHEMBL2073
|
P07947
|
Tyrosine-protein kinase YES |
88.79%
|
83.14%
|
|
CHEMBL4816
|
Q9Y243
|
Serine/threonine-protein kinase AKT3 |
88.69%
|
96.28%
|
|
CHEMBL4187
|
Q99250
|
Sodium channel protein type II alpha subunit |
88.58%
|
95.50%
|
|
CHEMBL2955
|
O95136
|
Sphingosine 1-phosphate receptor Edg-5 |
88.42%
|
92.86%
|
|
CHEMBL2781
|
P19634
|
Sodium/hydrogen exchanger 1 |
88.06%
|
90.24%
|
|
CHEMBL221
|
P23219
|
Cyclooxygenase-1 |
87.69%
|
90.17%
|
|
CHEMBL4393
|
P39900
|
Matrix metalloproteinase 12 |
87.27%
|
92.22%
|
|
CHEMBL4660
|
P28907
|
Lymphocyte differentiation antigen CD38 |
87.16%
|
95.27%
|
|
CHEMBL333
|
P08253
|
Matrix metalloproteinase-2 |
86.57%
|
96.31%
|
|
CHEMBL3776
|
Q14790
|
Caspase-8 |
86.44%
|
97.06%
|
|
CHEMBL3392948
|
Q9NP59
|
Solute carrier family 40 member 1 |
86.31%
|
95.00%
|
|
CHEMBL4478
|
Q00975
|
Voltage-gated N-type calcium channel alpha-1B subunit |
86.18%
|
97.14%
|
|
CHEMBL1907603
|
Q05586
|
Glutamate NMDA receptor; GRIN1/GRIN2B |
86.11%
|
95.89%
|
|
CHEMBL2319
|
P06870
|
Kallikrein 1 |
86.07%
|
90.95%
|
|
CHEMBL3018
|
Q9Y5Y6
|
Matriptase |
86.02%
|
98.33%
|
|
CHEMBL2094135
|
Q96BI3
|
Gamma-secretase |
85.92%
|
98.05%
|
|
CHEMBL255
|
P29275
|
Adenosine A2b receptor |
85.78%
|
98.59%
|
|
CHEMBL3430907
|
Q96GD4
|
Aurora kinase B/Inner centromere protein |
85.33%
|
97.50%
|
|
CHEMBL259
|
P32245
|
Melanocortin receptor 4 |
85.25%
|
95.38%
|
|
CHEMBL274
|
P51681
|
C-C chemokine receptor type 5 |
84.90%
|
98.77%
|
|
CHEMBL3267
|
P48736
|
PI3-kinase p110-gamma subunit |
83.77%
|
95.71%
|
|
CHEMBL2111367
|
P27986
|
PI3-kinase p110-alpha/p85-alpha |
83.69%
|
94.33%
|
|
CHEMBL2274
|
Q9H228
|
Sphingosine 1-phosphate receptor Edg-8 |
82.75%
|
100.00%
|
|
CHEMBL2534
|
O15530
|
3-phosphoinositide dependent protein kinase-1 |
82.58%
|
95.36%
|
|
CHEMBL4296
|
Q15858
|
Sodium channel protein type IX alpha subunit |
82.38%
|
96.11%
|
|
CHEMBL4394
|
Q9NYA1
|
Sphingosine kinase 1 |
82.13%
|
96.03%
|
|
CHEMBL4618
|
P09960
|
Leukotriene A4 hydrolase |
81.91%
|
97.86%
|
|
CHEMBL2885
|
P07451
|
Carbonic anhydrase III |
81.85%
|
87.45%
|
|
CHEMBL4073
|
P09237
|
Matrix metalloproteinase 7 |
81.83%
|
97.56%
|
|
CHEMBL2007625
|
O75874
|
Isocitrate dehydrogenase [NADP] cytoplasmic |
81.76%
|
99.00%
|
|
CHEMBL249
|
P25103
|
Neurokinin 1 receptor |
81.56%
|
99.17%
|
|
CHEMBL332
|
P03956
|
Matrix metalloproteinase-1 |
81.39%
|
94.50%
|
|
CHEMBL1907600
|
Q00535
|
Cyclin-dependent kinase 5/CDK5 activator 1 |
81.08%
|
93.03%
|
|
CHEMBL2413
|
P32246
|
C-C chemokine receptor type 1 |
81.05%
|
89.50%
|
|
CHEMBL3145
|
P42338
|
PI3-kinase p110-beta subunit |
80.93%
|
98.75%
|
|
CHEMBL1873
|
P00750
|
Tissue-type plasminogen activator |
80.85%
|
93.33%
|
|
CHEMBL3892
|
Q99500
|
Sphingosine 1-phosphate receptor Edg-3 |
80.33%
|
97.29%
|